| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/EUHJ.2002.3291 |
| P698 | PubMed publication ID | 12473255 |
| P2093 | author name string | D J van Veldhuisen | |
| N J G M Veeger | |||
| J G P Tijssen | |||
| A J van Boven | |||
| A J Withagen | |||
| A H Liem | |||
| R M Robles de Medina | |||
| FLuvastatin On Risk Diminishment after Acute myocardial infarction study group | |||
| P433 | issue | 24 | |
| P921 | main subject | myocardial infarction | Q12152 |
| acute myocardial infarction | Q18558122 | ||
| P304 | page(s) | 1931-1937 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial | |
| P478 | volume | 23 |
| Q37140087 | Adjunctive interventions in myocardial infarction: the role of statin therapy |
| Q36865086 | Aggressive statin therapy for acute coronary syndromes |
| Q31101617 | All cholesterol-lowering interventions are expected to reduce stroke: Confirmatory data from IMPROVE-IT. |
| Q38824464 | Anti-Thrombotic Effects of Statins in Acute Coronary Syndromes: At the Intersection of Thrombosis, Inflammation, and Platelet-Leukocyte Interactions |
| Q36957803 | Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events |
| Q42859163 | Attainment of Canadian and European guidelines’ lipid targets with atorvastatin plus ezetimibe vs. doubling the dose of atorvastatin |
| Q36536175 | Cholesterol lowering for secondary prevention: what statin dose should we use? |
| Q36218278 | Comparative Effectiveness of Statin Therapy in Chronic Kidney Disease and Acute Myocardial Infarction: A Retrospective Cohort Study |
| Q34980772 | Consensus statement on management of dyslipidemia in Indian subjects |
| Q36704264 | Contemporary diagnosis and management of hypercholesterolemia in elderly acute myocardial infarction patients: a population-based study. |
| Q36707388 | Diagnostic and prognostic value of ambulatory ECG (Holter) monitoring in patients with coronary heart disease: a review |
| Q44454389 | Effect of atorvastatin (80 mg) on recurrent ischemia in unstable angina pectoris or non-ST-elevation acute myocardial infarction |
| Q37981596 | Effect of statins on ventricular tachyarrhythmia, cardiac arrest, and sudden cardiac death: a meta-analysis of published and unpublished evidence from randomized trials |
| Q36912033 | Efficacy and safety of statin monotherapy in older adults: a meta-analysis |
| Q34142678 | Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials |
| Q24806340 | Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696] |
| Q35807245 | Fluvastatin: clinical and safety profile |
| Q80675789 | Immediate effect of fluvastatin on lipid levels in acute coronary syndrome |
| Q35197128 | In-hospital initiation of statin therapy in patients with acute coronary events |
| Q52951792 | Increasing burden of treatment in the acute coronary syndromes: is it justified? |
| Q36600272 | Intensive statin therapy for treating acute coronary syndromes |
| Q37140094 | Intensive statin therapy in acute coronary syndromes |
| Q24630160 | Jupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean? |
| Q35826088 | Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes |
| Q41633477 | Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysis |
| Q36812973 | Statin therapy and mortalitiy in patients with ST-segment elevation myocardial infarction treated with primary angioplasty |
| Q36288354 | Statin therapy: a potentially useful peri-operative intervention in patients with cardiovascular disease |
| Q83283656 | Statins and hypertension |
| Q35783702 | Statins and liver toxicity: a meta-analysis |
| Q36768488 | Statins as first-line therapy for acute coronary syndrome? |
| Q24193862 | Statins for acute coronary syndrome |
| Q24236697 | Statins for acute coronary syndrome |
| Q38025837 | Statins in acute coronary syndrome: very early initiation and benefits |
| Q36014026 | Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice |
| Q37276466 | Statins in the first-line therapy of acute coronary syndrome - similar to aspirin? |
| Q28200294 | Statins in the treatment of chronic heart failure: a systematic review |
| Q33671245 | The effect of dyslipidemic drugs on mortality: A meta-analysis |
| Q35674095 | The next step in cardiovascular protection |
| Q46756852 | The pharmaco-economics of peri-operative statin therapy |
| Q37470209 | Update on statin-mediated anti-inflammatory activities in atherosclerosis |
| Q34408660 | Update on the efficacy of statin treatment in acute coronary syndromes |
| Q44650110 | Usefulness of elevated neopterin and C-reactive protein levels in predicting cardiovascular events in patients with non–Q-wave myocardial infarction |
| Q37980478 | Very early initiation of statin therapy and mortality in patients with acute coronary syndrome |
Search more.